2025-04-14 12:36:11
Latest Post
IPO-bound Belrise Industries Ltd completes strategic acquisition of H-One India Private Limited
Mitsu Chem Plast Eyes ₹ 1,000 Cr Revenue by 2028
Aurobindo Pharma receives final ANDA approval for Rivaroxaban Tablets USP, 2.5mg
NHPC Ltd commissions commercial operation of 107.14 MW of 300 MW Karnisar Solar Power Plant
Nureca Limited's Manufacturing Subsidiary Secures US FDA Registration
Stock Report
Shree Ganesh Remedies Q4FY22 net profit slips QoQ to Rs. 3.83 crores
Posted On : 2022-05-06 16:19:16( TIMEZONE : IST )
Shree Ganesh Remedies Ltd has reported Standalone financial results for the period ended March 31, 2022.
Financial Results (Q4 FY2022) - QoQ Comparison
The company has reported total income of Rs. 21.6951 crores during the period ended March 31, 2022 as compared to Rs. 22.0068 crores during the period ended December 31, 2021.
The company has posted net profit / (loss) of Rs. 3.8393 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs. 4.2026 crores for the period ended December 31, 2021.
The company has reported EPS of Rs. 3.20 for the period ended March 31, 2022 as compared to Rs. 3.50 for the period ended December 31, 2021.
| Financials | Q4 FY2022 | Q3 FY2022 | % Change |
| Total Income | ₹ 21.6951 crs | ₹22.0068 crs |  -1.42% |
| Net Profit | ₹3.8393 crs | ₹4.2026 crs | -8.64% |
| EPS | ₹3.20 | ₹3.50 | -8.57% |
Financial Results (Q4 FY2022) - YoY Comparison
The company has reported total income of Rs. 21.6951 crores during the period ended March 31, 2022 as compared to Rs.15.5227 crores during the period ended March 31, 2021.
The company has posted net profit / (loss) of Rs.3.8393 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs.3.0290 crores for the period ended March 31, 2021.
The company has reported EPS of Rs.3.20 for the period ended March 31, 2022 as compared to Rs.3.03 for the period ended March 31, 2021.
| Financials | Q4 FY2022 | Q4 FY2021 | % Change |
| Total Income | ₹ 21.6951 crs | ₹15.5227 crs |  39.76% |
| Net Profit | ₹3.8393 crs | ₹3.0290 crs | 26.75% |
| EPS | ₹3.20 | ₹3.03 | 5.61% |
Financial Results (Year Ended FY2022) - YoY Comparison
The company has reported total income of Rs.74.8561 crores during the Financial Year ended March 31, 2022 as compared to Rs.51.1766 crores during the Financial Year ended March 31, 2021.
The company has posted net profit / (loss) of Rs.13.3986 crores for the Financial Year ended March 31, 2022 as against net profit / (loss) of Rs.9.7542 crores for the Financial Year ended March 31, 2021.
The company has reported EPS of Rs.11.16 for the Financial Year ended March 31, 2022 as compared to Rs.8.12 for the Financial Year ended March 31, 2021.
| Financials | Year Ended FY2022 | Year Ended FY2021 | % Change |
| Total Income | ₹74.8561 crs | ₹51.1766 crs | 46.27% |
| Net Profit | ₹13.3986 crs | ₹9.7542 crs | 37.36% |
| EPS | ₹11.16 | ₹8.12 | 37.44% |
Shares of Shree Ganesh Remedies Ltd was last trading in BSE at Rs. 315.95 as compared to the previous close of Rs. 317.15. The total number of shares traded during the day was 5763 in over 385 trades.
The stock hit an intraday high of Rs. 329.95 and intraday low of 305.25. The net turnover during the day was Rs. 1807920.00.
